Global Swine Influenza Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Swine Influenza Vaccines market size was valued at US$ 121.3 million in 2023. With growing demand in downstream market, the Swine Influenza Vaccines is forecast to a readjusted size of US$ 164.6 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Swine Influenza Vaccines market. Swine Influenza Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Influenza Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Influenza Vaccines market.
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The report on Swine Influenza Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Influenza Vaccines market. It may include historical data, market segmentation by Type (e.g., Live Vaccines, Killed Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Influenza Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Influenza Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Swine Influenza Vaccines industry. This include advancements in Swine Influenza Vaccines technology, Swine Influenza Vaccines new entrants, Swine Influenza Vaccines new investment, and other innovations that are shaping the future of Swine Influenza Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Influenza Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Influenza Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Influenza Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Influenza Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Influenza Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Influenza Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Influenza Vaccines market.
Market Segmentation:
Swine Influenza Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Swine Influenza Vaccines market?
What factors are driving Swine Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Influenza Vaccines market opportunities vary by end market size?
How does Swine Influenza Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Swine Influenza Vaccines market size was valued at US$ 121.3 million in 2023. With growing demand in downstream market, the Swine Influenza Vaccines is forecast to a readjusted size of US$ 164.6 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Swine Influenza Vaccines market. Swine Influenza Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Influenza Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Influenza Vaccines market.
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The report on Swine Influenza Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Influenza Vaccines market. It may include historical data, market segmentation by Type (e.g., Live Vaccines, Killed Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Influenza Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Influenza Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Swine Influenza Vaccines industry. This include advancements in Swine Influenza Vaccines technology, Swine Influenza Vaccines new entrants, Swine Influenza Vaccines new investment, and other innovations that are shaping the future of Swine Influenza Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Influenza Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Influenza Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Influenza Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Influenza Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Influenza Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Influenza Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Influenza Vaccines market.
Market Segmentation:
Swine Influenza Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Live Vaccines
- Killed Vaccines
- Commodity Pig
- Breeding Pig
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chengdu TECBOND
- Green Cross Veterinary
- Hipra
- MSD Animal Health (Merck)
- Zoetis
- CAHIC
- Boehringer Ingelheim
- Ceva
- Ringpu Biology
- DHN
What is the 10-year outlook for the global Swine Influenza Vaccines market?
What factors are driving Swine Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Influenza Vaccines market opportunities vary by end market size?
How does Swine Influenza Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Influenza Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Swine Influenza Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Swine Influenza Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Swine Influenza Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Swine Influenza Vaccines Sales by Type
2.3.1 Global Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Swine Influenza Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Swine Influenza Vaccines Sale Price by Type (2019-2024)
2.4 Swine Influenza Vaccines Segment by Application
2.4.1 Commodity Pig
2.4.2 Breeding Pig
2.5 Swine Influenza Vaccines Sales by Application
2.5.1 Global Swine Influenza Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Swine Influenza Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Swine Influenza Vaccines Sale Price by Application (2019-2024)
3 GLOBAL SWINE INFLUENZA VACCINES BY COMPANY
3.1 Global Swine Influenza Vaccines Breakdown Data by Company
3.1.1 Global Swine Influenza Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Swine Influenza Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Swine Influenza Vaccines Revenue by Company (2019-2024)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Swine Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Influenza Vaccines Product Location Distribution
3.4.2 Players Swine Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SWINE INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Influenza Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Swine Influenza Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Swine Influenza Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Influenza Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Swine Influenza Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Swine Influenza Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Influenza Vaccines Sales Growth
4.4 APAC Swine Influenza Vaccines Sales Growth
4.5 Europe Swine Influenza Vaccines Sales Growth
4.6 Middle East & Africa Swine Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Influenza Vaccines Sales by Country
5.1.1 Americas Swine Influenza Vaccines Sales by Country (2019-2024)
5.1.2 Americas Swine Influenza Vaccines Revenue by Country (2019-2024)
5.2 Americas Swine Influenza Vaccines Sales by Type
5.3 Americas Swine Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Influenza Vaccines Sales by Region
6.1.1 APAC Swine Influenza Vaccines Sales by Region (2019-2024)
6.1.2 APAC Swine Influenza Vaccines Revenue by Region (2019-2024)
6.2 APAC Swine Influenza Vaccines Sales by Type
6.3 APAC Swine Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Influenza Vaccines by Country
7.1.1 Europe Swine Influenza Vaccines Sales by Country (2019-2024)
7.1.2 Europe Swine Influenza Vaccines Revenue by Country (2019-2024)
7.2 Europe Swine Influenza Vaccines Sales by Type
7.3 Europe Swine Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Influenza Vaccines by Country
8.1.1 Middle East & Africa Swine Influenza Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Swine Influenza Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Influenza Vaccines Sales by Type
8.3 Middle East & Africa Swine Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Influenza Vaccines
10.3 Manufacturing Process Analysis of Swine Influenza Vaccines
10.4 Industry Chain Structure of Swine Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Influenza Vaccines Distributors
11.3 Swine Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Swine Influenza Vaccines Forecast by Region (2025-2030)
12.1.2 Global Swine Influenza Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Influenza Vaccines Forecast by Type
12.7 Global Swine Influenza Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chengdu TECBOND
13.1.1 Chengdu TECBOND Company Information
13.1.2 Chengdu TECBOND Swine Influenza Vaccines Product Portfolios and Specifications
13.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chengdu TECBOND Main Business Overview
13.1.5 Chengdu TECBOND Latest Developments
13.2 Green Cross Veterinary
13.2.1 Green Cross Veterinary Company Information
13.2.2 Green Cross Veterinary Swine Influenza Vaccines Product Portfolios and Specifications
13.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Green Cross Veterinary Main Business Overview
13.2.5 Green Cross Veterinary Latest Developments
13.3 Hipra
13.3.1 Hipra Company Information
13.3.2 Hipra Swine Influenza Vaccines Product Portfolios and Specifications
13.3.3 Hipra Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hipra Main Business Overview
13.3.5 Hipra Latest Developments
13.4 MSD Animal Health (Merck)
13.4.1 MSD Animal Health (Merck) Company Information
13.4.2 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MSD Animal Health (Merck) Main Business Overview
13.4.5 MSD Animal Health (Merck) Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Swine Influenza Vaccines Product Portfolios and Specifications
13.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Swine Influenza Vaccines Product Portfolios and Specifications
13.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Swine Influenza Vaccines Product Portfolios and Specifications
13.8.3 Ceva Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Ringpu Biology
13.9.1 Ringpu Biology Company Information
13.9.2 Ringpu Biology Swine Influenza Vaccines Product Portfolios and Specifications
13.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ringpu Biology Main Business Overview
13.9.5 Ringpu Biology Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Swine Influenza Vaccines Product Portfolios and Specifications
13.10.3 DHN Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Influenza Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Swine Influenza Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Swine Influenza Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Swine Influenza Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Swine Influenza Vaccines Sales by Type
2.3.1 Global Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Swine Influenza Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Swine Influenza Vaccines Sale Price by Type (2019-2024)
2.4 Swine Influenza Vaccines Segment by Application
2.4.1 Commodity Pig
2.4.2 Breeding Pig
2.5 Swine Influenza Vaccines Sales by Application
2.5.1 Global Swine Influenza Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Swine Influenza Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Swine Influenza Vaccines Sale Price by Application (2019-2024)
3 GLOBAL SWINE INFLUENZA VACCINES BY COMPANY
3.1 Global Swine Influenza Vaccines Breakdown Data by Company
3.1.1 Global Swine Influenza Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Swine Influenza Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Swine Influenza Vaccines Revenue by Company (2019-2024)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Swine Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Influenza Vaccines Product Location Distribution
3.4.2 Players Swine Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SWINE INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Influenza Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Swine Influenza Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Swine Influenza Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Influenza Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Swine Influenza Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Swine Influenza Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Influenza Vaccines Sales Growth
4.4 APAC Swine Influenza Vaccines Sales Growth
4.5 Europe Swine Influenza Vaccines Sales Growth
4.6 Middle East & Africa Swine Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Influenza Vaccines Sales by Country
5.1.1 Americas Swine Influenza Vaccines Sales by Country (2019-2024)
5.1.2 Americas Swine Influenza Vaccines Revenue by Country (2019-2024)
5.2 Americas Swine Influenza Vaccines Sales by Type
5.3 Americas Swine Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Influenza Vaccines Sales by Region
6.1.1 APAC Swine Influenza Vaccines Sales by Region (2019-2024)
6.1.2 APAC Swine Influenza Vaccines Revenue by Region (2019-2024)
6.2 APAC Swine Influenza Vaccines Sales by Type
6.3 APAC Swine Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Influenza Vaccines by Country
7.1.1 Europe Swine Influenza Vaccines Sales by Country (2019-2024)
7.1.2 Europe Swine Influenza Vaccines Revenue by Country (2019-2024)
7.2 Europe Swine Influenza Vaccines Sales by Type
7.3 Europe Swine Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Influenza Vaccines by Country
8.1.1 Middle East & Africa Swine Influenza Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Swine Influenza Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Influenza Vaccines Sales by Type
8.3 Middle East & Africa Swine Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Influenza Vaccines
10.3 Manufacturing Process Analysis of Swine Influenza Vaccines
10.4 Industry Chain Structure of Swine Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Influenza Vaccines Distributors
11.3 Swine Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Swine Influenza Vaccines Forecast by Region (2025-2030)
12.1.2 Global Swine Influenza Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Influenza Vaccines Forecast by Type
12.7 Global Swine Influenza Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chengdu TECBOND
13.1.1 Chengdu TECBOND Company Information
13.1.2 Chengdu TECBOND Swine Influenza Vaccines Product Portfolios and Specifications
13.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chengdu TECBOND Main Business Overview
13.1.5 Chengdu TECBOND Latest Developments
13.2 Green Cross Veterinary
13.2.1 Green Cross Veterinary Company Information
13.2.2 Green Cross Veterinary Swine Influenza Vaccines Product Portfolios and Specifications
13.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Green Cross Veterinary Main Business Overview
13.2.5 Green Cross Veterinary Latest Developments
13.3 Hipra
13.3.1 Hipra Company Information
13.3.2 Hipra Swine Influenza Vaccines Product Portfolios and Specifications
13.3.3 Hipra Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hipra Main Business Overview
13.3.5 Hipra Latest Developments
13.4 MSD Animal Health (Merck)
13.4.1 MSD Animal Health (Merck) Company Information
13.4.2 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MSD Animal Health (Merck) Main Business Overview
13.4.5 MSD Animal Health (Merck) Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Swine Influenza Vaccines Product Portfolios and Specifications
13.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Swine Influenza Vaccines Product Portfolios and Specifications
13.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Swine Influenza Vaccines Product Portfolios and Specifications
13.8.3 Ceva Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Ringpu Biology
13.9.1 Ringpu Biology Company Information
13.9.2 Ringpu Biology Swine Influenza Vaccines Product Portfolios and Specifications
13.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ringpu Biology Main Business Overview
13.9.5 Ringpu Biology Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Swine Influenza Vaccines Product Portfolios and Specifications
13.10.3 DHN Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Swine Influenza Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Swine Influenza Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 6. Global Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Swine Influenza Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Swine Influenza Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Swine Influenza Vaccines Sale Price by Type (2019-2024) & (USD/K Unit)
Table 10. Global Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 11. Global Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global Swine Influenza Vaccines Revenue by Application (2019-2024)
Table 13. Global Swine Influenza Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Swine Influenza Vaccines Sale Price by Application (2019-2024) & (USD/K Unit)
Table 15. Global Swine Influenza Vaccines Sales by Company (2019-2024) & (M Units)
Table 16. Global Swine Influenza Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Swine Influenza Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Swine Influenza Vaccines Sale Price by Company (2019-2024) & (USD/K Unit)
Table 20. Key Manufacturers Swine Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Swine Influenza Vaccines Products Offered
Table 22. Swine Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Swine Influenza Vaccines Sales by Geographic Region (2019-2024) & (M Units)
Table 26. Global Swine Influenza Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Swine Influenza Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Swine Influenza Vaccines Sales by Country/Region (2019-2024) & (M Units)
Table 30. Global Swine Influenza Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Swine Influenza Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Swine Influenza Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 34. Americas Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 38. Americas Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 39. APAC Swine Influenza Vaccines Sales by Region (2019-2024) & (M Units)
Table 40. APAC Swine Influenza Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC Swine Influenza Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Swine Influenza Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 44. APAC Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 45. Europe Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 46. Europe Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 50. Europe Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 51. Middle East & Africa Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 52. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 56. Middle East & Africa Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 57. Key Market Drivers & Growth Opportunities of Swine Influenza Vaccines
Table 58. Key Market Challenges & Risks of Swine Influenza Vaccines
Table 59. Key Industry Trends of Swine Influenza Vaccines
Table 60. Swine Influenza Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Swine Influenza Vaccines Distributors List
Table 63. Swine Influenza Vaccines Customer List
Table 64. Global Swine Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 65. Global Swine Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 67. Americas Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Swine Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 69. APAC Swine Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 71. Europe Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 73. Middle East & Africa Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Swine Influenza Vaccines Sales Forecast by Type (2025-2030) & (M Units)
Table 75. Global Swine Influenza Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Swine Influenza Vaccines Sales Forecast by Application (2025-2030) & (M Units)
Table 77. Global Swine Influenza Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Chengdu TECBOND Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu TECBOND Swine Influenza Vaccines Product Portfolios and Specifications
Table 80. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 81. Chengdu TECBOND Main Business
Table 82. Chengdu TECBOND Latest Developments
Table 83. Green Cross Veterinary Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Green Cross Veterinary Swine Influenza Vaccines Product Portfolios and Specifications
Table 85. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 86. Green Cross Veterinary Main Business
Table 87. Green Cross Veterinary Latest Developments
Table 88. Hipra Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Hipra Swine Influenza Vaccines Product Portfolios and Specifications
Table 90. Hipra Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 91. Hipra Main Business
Table 92. Hipra Latest Developments
Table 93. MSD Animal Health (Merck) Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolios and Specifications
Table 95. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 96. MSD Animal Health (Merck) Main Business
Table 97. MSD Animal Health (Merck) Latest Developments
Table 98. Zoetis Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Swine Influenza Vaccines Product Portfolios and Specifications
Table 100. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. CAHIC Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. CAHIC Swine Influenza Vaccines Product Portfolios and Specifications
Table 105. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 106. CAHIC Main Business
Table 107. CAHIC Latest Developments
Table 108. Boehringer Ingelheim Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolios and Specifications
Table 110. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Ceva Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Ceva Swine Influenza Vaccines Product Portfolios and Specifications
Table 115. Ceva Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 116. Ceva Main Business
Table 117. Ceva Latest Developments
Table 118. Ringpu Biology Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Ringpu Biology Swine Influenza Vaccines Product Portfolios and Specifications
Table 120. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 121. Ringpu Biology Main Business
Table 122. Ringpu Biology Latest Developments
Table 123. DHN Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Swine Influenza Vaccines Product Portfolios and Specifications
Table 125. DHN Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 1. Swine Influenza Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Swine Influenza Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 6. Global Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Swine Influenza Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Swine Influenza Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Swine Influenza Vaccines Sale Price by Type (2019-2024) & (USD/K Unit)
Table 10. Global Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 11. Global Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global Swine Influenza Vaccines Revenue by Application (2019-2024)
Table 13. Global Swine Influenza Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Swine Influenza Vaccines Sale Price by Application (2019-2024) & (USD/K Unit)
Table 15. Global Swine Influenza Vaccines Sales by Company (2019-2024) & (M Units)
Table 16. Global Swine Influenza Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Swine Influenza Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Swine Influenza Vaccines Sale Price by Company (2019-2024) & (USD/K Unit)
Table 20. Key Manufacturers Swine Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Swine Influenza Vaccines Products Offered
Table 22. Swine Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Swine Influenza Vaccines Sales by Geographic Region (2019-2024) & (M Units)
Table 26. Global Swine Influenza Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Swine Influenza Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Swine Influenza Vaccines Sales by Country/Region (2019-2024) & (M Units)
Table 30. Global Swine Influenza Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Swine Influenza Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Swine Influenza Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 34. Americas Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 38. Americas Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 39. APAC Swine Influenza Vaccines Sales by Region (2019-2024) & (M Units)
Table 40. APAC Swine Influenza Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC Swine Influenza Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Swine Influenza Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 44. APAC Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 45. Europe Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 46. Europe Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 50. Europe Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 51. Middle East & Africa Swine Influenza Vaccines Sales by Country (2019-2024) & (M Units)
Table 52. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Swine Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Swine Influenza Vaccines Sales by Type (2019-2024) & (M Units)
Table 56. Middle East & Africa Swine Influenza Vaccines Sales by Application (2019-2024) & (M Units)
Table 57. Key Market Drivers & Growth Opportunities of Swine Influenza Vaccines
Table 58. Key Market Challenges & Risks of Swine Influenza Vaccines
Table 59. Key Industry Trends of Swine Influenza Vaccines
Table 60. Swine Influenza Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Swine Influenza Vaccines Distributors List
Table 63. Swine Influenza Vaccines Customer List
Table 64. Global Swine Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 65. Global Swine Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 67. Americas Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Swine Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 69. APAC Swine Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 71. Europe Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Swine Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 73. Middle East & Africa Swine Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Swine Influenza Vaccines Sales Forecast by Type (2025-2030) & (M Units)
Table 75. Global Swine Influenza Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Swine Influenza Vaccines Sales Forecast by Application (2025-2030) & (M Units)
Table 77. Global Swine Influenza Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Chengdu TECBOND Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu TECBOND Swine Influenza Vaccines Product Portfolios and Specifications
Table 80. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 81. Chengdu TECBOND Main Business
Table 82. Chengdu TECBOND Latest Developments
Table 83. Green Cross Veterinary Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Green Cross Veterinary Swine Influenza Vaccines Product Portfolios and Specifications
Table 85. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 86. Green Cross Veterinary Main Business
Table 87. Green Cross Veterinary Latest Developments
Table 88. Hipra Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Hipra Swine Influenza Vaccines Product Portfolios and Specifications
Table 90. Hipra Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 91. Hipra Main Business
Table 92. Hipra Latest Developments
Table 93. MSD Animal Health (Merck) Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolios and Specifications
Table 95. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 96. MSD Animal Health (Merck) Main Business
Table 97. MSD Animal Health (Merck) Latest Developments
Table 98. Zoetis Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Swine Influenza Vaccines Product Portfolios and Specifications
Table 100. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. CAHIC Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. CAHIC Swine Influenza Vaccines Product Portfolios and Specifications
Table 105. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 106. CAHIC Main Business
Table 107. CAHIC Latest Developments
Table 108. Boehringer Ingelheim Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolios and Specifications
Table 110. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Ceva Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Ceva Swine Influenza Vaccines Product Portfolios and Specifications
Table 115. Ceva Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 116. Ceva Main Business
Table 117. Ceva Latest Developments
Table 118. Ringpu Biology Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Ringpu Biology Swine Influenza Vaccines Product Portfolios and Specifications
Table 120. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 121. Ringpu Biology Main Business
Table 122. Ringpu Biology Latest Developments
Table 123. DHN Basic Information, Swine Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Swine Influenza Vaccines Product Portfolios and Specifications
Table 125. DHN Swine Influenza Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Influenza Vaccines
Figure 2. Swine Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Influenza Vaccines Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Swine Influenza Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Swine Influenza Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Swine Influenza Vaccines Sales Market Share by Type in 2023
Figure 12. Global Swine Influenza Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. Swine Influenza Vaccines Consumed in Commodity Pig
Figure 14. Global Swine Influenza Vaccines Market: Commodity Pig (2019-2024) & (M Units)
Figure 15. Swine Influenza Vaccines Consumed in Breeding Pig
Figure 16. Global Swine Influenza Vaccines Market: Breeding Pig (2019-2024) & (M Units)
Figure 17. Global Swine Influenza Vaccines Sales Market Share by Application (2023)
Figure 18. Global Swine Influenza Vaccines Revenue Market Share by Application in 2023
Figure 19. Swine Influenza Vaccines Sales Market by Company in 2023 (M Units)
Figure 20. Global Swine Influenza Vaccines Sales Market Share by Company in 2023
Figure 21. Swine Influenza Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Swine Influenza Vaccines Revenue Market Share by Company in 2023
Figure 23. Global Swine Influenza Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 26. Americas Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 27. APAC Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 28. APAC Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. Europe Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 30. Europe Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 32. Middle East & Africa Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Americas Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 34. Americas Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 35. Americas Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 36. Americas Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 37. United States Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Swine Influenza Vaccines Sales Market Share by Region in 2023
Figure 42. APAC Swine Influenza Vaccines Revenue Market Share by Regions in 2023
Figure 43. APAC Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 44. APAC Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 45. China Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 53. Europe Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 54. Europe Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 55. Europe Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 56. Germany Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 65. Egypt Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Swine Influenza Vaccines in 2023
Figure 71. Manufacturing Process Analysis of Swine Influenza Vaccines
Figure 72. Industry Chain Structure of Swine Influenza Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Swine Influenza Vaccines Sales Market Forecast by Region (2025-2030)
Figure 75. Global Swine Influenza Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Swine Influenza Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Swine Influenza Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Swine Influenza Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Swine Influenza Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Swine Influenza Vaccines
Figure 2. Swine Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Influenza Vaccines Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Swine Influenza Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Swine Influenza Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Swine Influenza Vaccines Sales Market Share by Type in 2023
Figure 12. Global Swine Influenza Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. Swine Influenza Vaccines Consumed in Commodity Pig
Figure 14. Global Swine Influenza Vaccines Market: Commodity Pig (2019-2024) & (M Units)
Figure 15. Swine Influenza Vaccines Consumed in Breeding Pig
Figure 16. Global Swine Influenza Vaccines Market: Breeding Pig (2019-2024) & (M Units)
Figure 17. Global Swine Influenza Vaccines Sales Market Share by Application (2023)
Figure 18. Global Swine Influenza Vaccines Revenue Market Share by Application in 2023
Figure 19. Swine Influenza Vaccines Sales Market by Company in 2023 (M Units)
Figure 20. Global Swine Influenza Vaccines Sales Market Share by Company in 2023
Figure 21. Swine Influenza Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Swine Influenza Vaccines Revenue Market Share by Company in 2023
Figure 23. Global Swine Influenza Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Swine Influenza Vaccines Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 26. Americas Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 27. APAC Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 28. APAC Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. Europe Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 30. Europe Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Swine Influenza Vaccines Sales 2019-2024 (M Units)
Figure 32. Middle East & Africa Swine Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Americas Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 34. Americas Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 35. Americas Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 36. Americas Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 37. United States Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Swine Influenza Vaccines Sales Market Share by Region in 2023
Figure 42. APAC Swine Influenza Vaccines Revenue Market Share by Regions in 2023
Figure 43. APAC Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 44. APAC Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 45. China Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 53. Europe Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 54. Europe Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 55. Europe Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 56. Germany Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Swine Influenza Vaccines Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Swine Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 65. Egypt Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Swine Influenza Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Swine Influenza Vaccines in 2023
Figure 71. Manufacturing Process Analysis of Swine Influenza Vaccines
Figure 72. Industry Chain Structure of Swine Influenza Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Swine Influenza Vaccines Sales Market Forecast by Region (2025-2030)
Figure 75. Global Swine Influenza Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Swine Influenza Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Swine Influenza Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Swine Influenza Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Swine Influenza Vaccines Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Digital Biomarker Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
121 pages
Global Gabapentin Enacarbil Market Growth 2023-2029
US$ 3,660.00
February 2023
115 pages
Global Cell Expansion Disposable Market Growth 2024-2030
US$ 3,660.00
December 2024
114 pages
Global Multiple Chamber Prefilled Syringe Market Growth 2024-2030
US$ 3,660.00
March 2024
90 pages
Global Covid-19 Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
128 pages
